Prana Capital Management’s Centene CNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256K Buy
+7,821
New +$321K 0.01% 127
2025
Q3
Sell
-41,466
Closed -$2.25M 116
2025
Q2
$2.25M Buy
41,466
+3,641
+10% +$214K 0.08% 81
2025
Q1
$2.3M Buy
37,825
+28,665
+313% +$1.73M 0.09% 81
2024
Q4
$555K Buy
+9,160
New +$571K 0.03% 93
2024
Q3
Sell
-56,938
Closed -$3.77M 95
2024
Q2
$3.77M Sell
56,938
-171,490
-75% -$12.5M 0.18% 69
2024
Q1
$17.9M Sell
228,428
-76,819
-25% -$5.93M 0.8% 40
2023
Q4
$22.7M Buy
305,247
+22,562
+8% +$1.63M 1.33% 26
2023
Q3
$19.5M Buy
282,685
+71,447
+34% +$4.75M 1.24% 29
2023
Q2
$14.2M Buy
211,238
+100,765
+91% +$6.72M 0.95% 34
2023
Q1
$6.98M Sell
110,473
-101,144
-48% -$7.18M 0.59% 43
2022
Q4
$17.4M Buy
211,617
+201,672
+2,028% +$16.5M 1.33% 27
2022
Q3
$774K Buy
+9,945
New +$889K 0.05% 70

Other funds holding CNC

Prana Capital Management's CNC Position: Q1 2026 in Review

Prana Capital Management opened a new position in Centene (CNC) in Q1 2026: 7,821 shares worth $256K. The stake represents 0.01% of the portfolio and ranks #127 among its holdings. This is a return to the name: Prana Capital Management previously reported a position in CNC as recently as Q2 2025.

Prana Capital Management first reported a position in CNC in Q3 2022 and has held it in 12 quarters since. The position peaked at $22.7M in Q4 2023. 863 funds tracked by Wall St. Rank hold CNC as of Q1 2026.

  • Prana Capital Management held 7,821 shares of Centene worth $256K as of Q1 2026.
  • Centene was a new Prana Capital Management position in Q1 2026.
  • Centene made up 0.01% of Prana Capital Management's portfolio in Q1 2026, its #127 holding.
  • Prana Capital Management first reported a position in Centene in Q3 2022 and has held it in 12 quarters since.
  • Prana Capital Management's Centene position peaked at $22.7M in Q4 2023.
  • 863 funds tracked by Wall St. Rank held Centene as of Q1 2026.

Based on Prana Capital Management's 13F filing for Q1 2026, filed 15 May 2026.